Philips invests in Common Sensing’s smart cap system
Patients with conditions such as diabetes depend on regular injections to stay healthy. But because they give the shots themselves, there’s usually no way for their providers to know if they’re using the medication correctly.
Common Sensing — based in Cambridge, Massachusetts — has a solution. The company’s Gocap system uses a smart cap that records dosage, timing and storage information of injectable medication, including insulin, fertility medications, growth hormones and others. Gocap can also share this data in real time to doctors, so they can make sure patients are getting the dosage they need. Philips sees huge potential in the company and has contributed to the company’s $6.6 million USD Series A financing round.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.